February 18, 2026

The U.S. Food and Drug Administration (FDA) has introduced a major regulatory shift in food labeling policy that directly impacts food manufacturers, regulatory teams, product developers, and labeling compliance professionals.

As of February 2026, the FDA will exercise enforcement discretion allowing companies to use “No Artificial Colors” claims when products contain naturally derived color additives, even if color has been added provided the color is not petroleum-based synthetic dye.

This marks a pivotal evolution in U.S. food additive regulation, color additive compliance, clean label strategy, and consumer transparency.

What Has Changed in FDA Policy

Previously, food products could only claim “No Artificial Colors” if no color additive was used at all including natural pigments.

Under the new approach:

Label Claim ConditionPrevious Interpretation2026 FDA Approach
Products contain natural color additivesCould NOT claim “No Artificial Colors”Claim now permitted
Product contains petroleum-based synthetic colorsClaim prohibitedStill prohibited
Product contains no added colorClaim allowedNo change

This enforcement discretion is intended to reduce consumer confusion and encourage industry transition toward natural color alternatives.

Newly Approved and Expanded Color Additives

FDA has simultaneously expanded available natural color options:

Color AdditiveSourceRegulatory Update
Beetroot RedNatural botanical sourceNewly approved
Spirulina ExtractAlgae-derived natural pigmentExpanded permitted uses

These approvals support the broader federal initiative to phase out petroleum-based synthetic dyes from the U.S. food supply.

Regulatory Context & Strategic Implications

This action aligns with:

  • FDA’s food chemical reassessment initiative
  • Increased scrutiny of petroleum-derived food dyes
  • Growing demand for clean label foods
  • Consumer preference for plant-based colorants
  • Global alignment with natural ingredient trends

However, enforcement discretion does not eliminate safety responsibilities. Manufacturers must still ensure:

  • Color additive authorization compliance
  • Purity and specification adherence
  • Supplier qualification and traceability
  • Stability and compatibility validation
  • Accurate ingredient declarations

Compliance Considerations for Food Manufacturers

1. Labeling Strategy Review

Companies should reassess packaging and marketing claims to align with the new policy.

2. Ingredient Documentation

Maintain regulatory documentation confirming the color source is naturally derived and FDA-authorized.

3. Supplier Qualification

Ensure color additive suppliers meet FDA safety, purity, and manufacturing standards.

4. Claim Substantiation

Avoid implying health superiority unless supported by approved claims.

5. Global Regulatory Alignment

Verify consistency with EU, Codex, and regional food color regulations.

Why This Matters in 2026

The FDA’s decision reflects a larger trend:

  • Transition toward natural food ingredient regulation
  • Strengthened oversight of synthetic additives
  • Expansion of clean-label compliance expectations
  • Greater transparency in food labeling laws

Food brands that proactively adapt can enhance consumer trust, brand positioning, and regulatory defensibility.

How Maven Regulatory Solutions Supports Food Color Compliance

Maven Regulatory Solutions provides:

  • Food additive regulatory strategy
  • Labeling and claim compliance reviews
  • Ingredient regulatory assessment
  • Clean-label transition planning
  • Supplier documentation audits
  • Risk assessment and enforcement readiness

Our experts help food manufacturers transition from synthetic dyes to compliant natural color alternatives while maintaining global regulatory alignment.

FAQ – FDA “No Artificial Colors” Policy

Can natural colors now be used with the claim?
Yes, if they are FDA-authorized and not petroleum-based.

Are synthetic dyes still allowed?
Only if authorized, but they cannot support the “No Artificial Colors” claim.

Does this mean natural colors are automatically safer?
No. Manufacturers remain responsible for demonstrating safety and compliance.

Is this a formal rule change?
FDA is exercising enforcement discretion meaning regulatory expectations still apply.